Your Search Returned 117 tagged news reports
The new test is said to be twice as accurate as the PSA (prostate specific antigen) blood test, which is notorious for giving false positives. Initial trials in Australia have been promising, say scientists at Sydney biotechnology company Minomic,
Australian men have been done a ''great disservice'' by a massive growth in prostate cancer diagnosis that has led to many receiving unnecessary and invasive treatment, experts say. Cancer Council NSW research has found detection of prostate cancer
The large amount of money that Medicare spends on PSA screening for prostate cancer provides little benefit for older men, according to a new study. Over three years, the Medicare fee-for-service program spent more than $450 million a year on PSA (
The hospital is sponsoring the screening, along with the urology clinic affiliated with the hospital. The advertisement gives guidelines for who should avail themselves of this service, including men as young as 35-years-old if there is a family
Diablo school board as interim superintendent prepares to leave Posted: 09/13/2013 04:03:49 PM PDT Updated: 09/13/2013 04:21:42 PM PDT This is an excerpt of On Assignment, education writer Theresa Harrington's blog on Contra Costa County schools.
Teenagers and men in their 20s and 30s are having controversial prostate cancer tests in a de facto screening program that is worrying some Australian doctors. GPs and cancer specialists say prominent men's health campaigns such as Movember may be
It is an 18 year follow-up of a study designed to show whether the use of the drug finasteride could reduce the incidence and deaths from prostate cancer. The study was called the Prostate Cancer Prevention Trial and when it was initially reported
Prostate cancer is the most common cancer in men...Although prostate cancer cases increase with age, still, only about 3% of men actually die from it. The American Cancer Society states that in 2013, approximately 238,590 new cases of prostate cancer
August 21, 2013 A discussion on Twitter caught the eyes of my colleagues yesterday, and raised a very interesting question: should insurance companies be allowed to do PSA testing to detect prostate cancer on men as a condition of getting insurance?
The decision to undergo PSA testing should be shared between patient and doctor, and men should be well counselled about the harms and benefits of early detection," said Professor Tony Costello, director of Urology at the Royal Melbourne Hospital and